(Q46508750)

English

Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib

scientific article published in July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18592270

Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18592270

0 references

1 reference

based on heuristic

inferred from title

Christian Bolenz

5

object named as

Christian Bolenz

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

author name string

Edwin Herrmann

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18592270

Joachim Gerss

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18592270

Stefan Bierer

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18592270

Thomas Köpke

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18592270

Lothar Hertle

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18592270

Christian Wülfing

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18592270

publication date

1 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18592270

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18592270

135

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18592270

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18592270

61-67

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18592270

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subjective and objective prospective, long-term analysis of quality of life during inhaled interleukin-2 immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sunitinib in patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal cell carcinoma guideline

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid deterioration in quality of life during interleukin-2- and alpha-interferon-based home therapy of renal cell carcinoma is associated with a good outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of sorafenib on symptoms and quality of life: results from a large randomized placebo-controlled study in renal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 2007

1 reference

https://pubmed.ncbi.nlm.nih.gov/18592270

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-008-0438-7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18592270

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18592270

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46508750&oldid=2207919282"